ARBUTUS BIOPHARMA CORP's ticker is ABUS and the CUSIP is 03879J100. A total of 110 filers reported holding ARBUTUS BIOPHARMA CORP in Q4 2023. The put-call ratio across all filers is 0.92 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $237,000 | +26.1% | 76,788 | +5.0% | 0.00% | – |
Q1 2024 | $188,000 | -29.9% | 73,146 | -31.8% | 0.00% | – |
Q4 2023 | $268,000 | +13.6% | 107,219 | -7.7% | 0.00% | – |
Q3 2023 | $236,000 | +972.7% | 116,174 | +1089.7% | 0.00% | – |
Q2 2023 | $22,000 | -92.1% | 9,765 | -89.4% | 0.00% | – |
Q1 2023 | $277,000 | +27.1% | 91,779 | -2.2% | 0.00% | – |
Q4 2022 | $218,000 | +23.2% | 93,843 | +1.4% | 0.00% | – |
Q3 2022 | $177,000 | -47.0% | 92,541 | -24.7% | 0.00% | – |
Q2 2022 | $334,000 | -13.9% | 122,967 | -5.5% | 0.00% | – |
Q1 2022 | $388,000 | -32.6% | 130,175 | -12.1% | 0.00% | – |
Q4 2021 | $576,000 | -7.1% | 148,090 | +2.5% | 0.00% | – |
Q3 2021 | $620,000 | +246.4% | 144,437 | +145.2% | 0.00% | – |
Q2 2021 | $179,000 | +8850.0% | 58,895 | +10089.4% | 0.00% | – |
Q1 2021 | $2,000 | -96.4% | 578 | -96.2% | 0.00% | – |
Q4 2020 | $55,000 | +27.9% | 15,376 | +10.8% | 0.00% | – |
Q3 2020 | $43,000 | +186.7% | 13,879 | +67.8% | 0.00% | – |
Q2 2020 | $15,000 | +400.0% | 8,269 | +242.7% | 0.00% | – |
Q1 2020 | $3,000 | 0.0% | 2,413 | +88.1% | 0.00% | – |
Q4 2019 | $3,000 | -72.7% | 1,283 | -82.3% | 0.00% | – |
Q3 2019 | $11,000 | -21.4% | 7,252 | +9.7% | 0.00% | – |
Q2 2019 | $14,000 | -39.1% | 6,610 | +0.6% | 0.00% | – |
Q1 2019 | $23,000 | -11.5% | 6,571 | -3.0% | 0.00% | – |
Q4 2018 | $26,000 | -75.0% | 6,773 | -38.7% | 0.00% | – |
Q3 2018 | $104,000 | +73.3% | 11,056 | +37.0% | 0.00% | – |
Q2 2018 | $60,000 | -20.0% | 8,073 | -46.2% | 0.00% | – |
Q1 2018 | $75,000 | +36.4% | 14,999 | +37.7% | 0.00% | – |
Q4 2017 | $55,000 | -14.1% | 10,895 | +5.2% | 0.00% | – |
Q3 2017 | $64,000 | +28.0% | 10,355 | -25.3% | 0.00% | – |
Q2 2017 | $50,000 | +8.7% | 13,855 | -0.9% | 0.00% | – |
Q1 2017 | $46,000 | -11.5% | 13,980 | -34.1% | 0.00% | – |
Q4 2016 | $52,000 | +15.6% | 21,230 | +63.9% | 0.00% | – |
Q3 2016 | $45,000 | -2.2% | 12,950 | -1.8% | 0.00% | – |
Q2 2016 | $46,000 | -17.9% | 13,190 | -2.9% | 0.00% | – |
Q1 2016 | $56,000 | -17.6% | 13,590 | -12.0% | 0.00% | – |
Q4 2015 | $68,000 | -84.1% | 15,450 | -78.0% | 0.00% | – |
Q3 2015 | $428,000 | – | 70,300 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management IV, LLC | 2,651,825 | $19,358,000 | 6.60% |
RTW INVESTMENTS, LP | 5,165,499 | $37,708,000 | 2.72% |
Eversept Partners, LP | 97,495 | $711,714 | 0.33% |
Seelaus Asset Management LLC | 14,300 | $104,000 | 0.09% |
LADENBURG THALMANN FINANCIAL SERVICES INC. | 1,765,315 | $8,827,000 | 0.08% |
ALGERT GLOBAL LLC | 34,816 | $254,000 | 0.05% |
BOOTHBAY FUND MANAGEMENT, LLC | 48,000 | $350,000 | 0.03% |
OXFORD ASSET MANAGEMENT LLP | 211,115 | $1,540,000 | 0.03% |
PRIMECAP MANAGEMENT CO/CA/ | 4,000,400 | $29,203,000 | 0.02% |
PDT Partners, LLC | 66,965 | $489,000 | 0.02% |